This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Practices of patient engagement in drug development: a systematic scoping review
Research Involvement and Engagement Open Access 29 June 2022
-
Formalising the induction of patient and public involvement contributors on trial oversight committees
Research Involvement and Engagement Open Access 17 June 2021
-
Patient Engagement Partnerships in Clinical Trials: Development of Patient Partner and Investigator Decision Aids
The Patient - Patient-Centered Outcomes Research Open Access 07 October 2020
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakradhar, S. Training on trials: Patients taught the language of drug development. Nat Med 21, 209–210 (2015). https://doi.org/10.1038/nm0315-209
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0315-209
This article is cited by
-
Practices of patient engagement in drug development: a systematic scoping review
Research Involvement and Engagement (2022)
-
Formalising the induction of patient and public involvement contributors on trial oversight committees
Research Involvement and Engagement (2021)
-
Patient Engagement Partnerships in Clinical Trials: Development of Patient Partner and Investigator Decision Aids
The Patient - Patient-Centered Outcomes Research (2020)
-
The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
Orphanet Journal of Rare Diseases (2019)
-
An integrated conceptual framework for evaluating and improving ‘understanding’ in informed consent
Trials (2017)